Skip to main content

The most talked about Sputnik vaccine is the first of its kind single-dose vaccine as compared to other vaccines like Covisheild and Covaxin which follow two dose regimens. Some say that Sputnik will be able to treat the mutated virus unlike other vaccines. But are these all mere speculations or will it really be able to tackle all the existing and upcoming variants, this is something only time will tell.

Sputnik V Light, Russia’s single-dose vaccine for Covid19 is expected to be launched in India soon, informed Russia Direct Investment Fund CEO Kirill Dmitriev on Friday. Earlier in the day, the first dose of Sputnik V Covid vaccine was also administered in India, becoming the third vaccine in the country which will now be used for inoculation drive.

“Sputnik V is a Russian-Indian vaccine. A big part of its production will be in India. We expect to produce more than 850 million doses of Sputnik V in India this year. We hope for the introduction of Sputnik V Lite in India soon,” Russian Direct Investment Fund CEO Kirill Dmitriev said. Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik V – the world’s first registered vaccine against coronavirus.

The single-dose Sputnik Light vaccine demonstrated 79.4% efficacy according to analyzed data taken from 28 days after the injection was administered as part of Russia’s mass vaccination program between 5 December 2020 and 15 April 2021. An efficacy level of almost 80% is higher than that of many two-dose vaccines. Sputnik Light has proven effective against all new strains of coronavirus, as demonstrated by the Gamaleya Center during laboratory tests.

InnoHEALTH magazine digital team

Author InnoHEALTH magazine digital team

More posts by InnoHEALTH magazine digital team

Leave a Reply